ecotek Clarifies Previous News Release
SINGAPORE, SINGAPORE-(Marketwire - Dec. 23, 2009) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced an update and clarification to the news release of December 15, 2009 titled “National Cancer Institute Selects Zecotek’s Tunable Green Fiber Laser for Applications in Flow Cytometry.”
Zecotek wishes to clarify that the new Tunable Green Fiber Laser (TGFL) provided to the National Institute of Health (USA) was assembled by Zecotek as a pre-production prototype sample. The warranty of the said pre-production laser is provided at this trial stage solely by Zecotek and not Fujikura. Results from NIH testing, together with feedback from major customers will be used as inputs to guide the final design features prior to the transfer for commercial production.
As such, the statements in the December 15th news release were released unilaterally by Zecotek without Fujikura’s contribution or revision.
Fujikura will manufacture the commercial production version of the TGFL in accordance with terms and conditions of the agreement and documented arrangements on distribution and labeling between Zecotek and Fujikura.
The present clarification is mutually agreed on by Zecotek and Fujikura.
About Zecotek
Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Zecotek Photonics Inc.
Michael Minder
(604) 827-5212
CHF Investor Relations
Christopher Haldane
Account Manager
(416) 868-1079 x237
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.